Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III CREDENCE trial of Invokana stopped early due to promising outcomes

July 17, 2018

RegenxBio initiates first-in-human trial of RGX-111 for treatment of MPS I

July 17, 2018

Neurotrope initiates enrollment in confirmatory phase II study of bryostatin-1

July 17, 2018

Promising data presented from completed pivotal study of PRO-140 with HAART for HIV-1

July 17, 2018

Concentric Analgesics initiates phase II trial of CA-008 to treat postsurgical pain

July 17, 2018

Rimeporide well tolerated in boys with Duchenne muscular dystrophy

July 17, 2018

Longitudinal study confirms fat, disputes sugar as obesity cause in mice

July 17, 2018

Animal model of HAAF provides insight on pathological process of the disease

July 17, 2018

Novel mouse model of miR-7-induced pancreatic beta-cell dedifferentiation

July 17, 2018

A mosaic HIV-1 vaccine is assessed in a phase I/IIa trial and in rhesus monkeys

July 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...